What is the next step in evaluating and treating a 42-year-old woman with markedly elevated aldosterone and plasma renin activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

This Patient Does NOT Have Primary Aldosteronism

With an aldosterone of 98 ng/dL and plasma renin activity of 18.42 ng/mL/h, this patient has an aldosterone-to-renin ratio (ARR) of only 5.3, which is far below the screening threshold of 30 and effectively rules out primary aldosteronism. 1 This is a normal physiologic response where both aldosterone and renin are elevated together, not the autonomous aldosterone production with suppressed renin that characterizes primary aldosteronism.

Understanding the Numbers

The key to interpreting these results is the aldosterone-to-renin ratio (ARR):

  • ARR = 98 ÷ 18.42 = 5.3
  • Screening threshold for primary aldosteronism: ARR > 30 1, 2
  • This patient's ratio is 6-fold lower than the diagnostic threshold

In primary aldosteronism, you would expect:

  • Elevated aldosterone (typically >10-15 ng/dL)
  • Suppressed renin (<1 ng/mL/h) 1
  • Elevated ARR (>30)

This patient has the opposite pattern—both hormones are elevated proportionally, suggesting secondary hyperaldosteronism or a high-renin state.

What This Pattern Actually Indicates

The simultaneous elevation of both aldosterone and renin suggests:

Most likely causes:

  • Renovascular hypertension (renal artery stenosis)—the renin-angiotensin system is appropriately activated 3
  • Malignant/accelerated hypertension—severe hypertension can drive both hormones up 4, 5
  • Diuretic use—stimulates both renin and aldosterone 1
  • Volume depletion or salt restriction—physiologic stimulus for both hormones
  • High-renin essential hypertension—a recognized phenotype in younger patients 6

Next Steps in Evaluation

1. Immediate Assessment

  • Measure blood pressure urgently—if severely elevated (>180/110 mmHg), this could represent malignant hypertension 4, 5
  • Check serum potassium—hypokalemia with this pattern suggests severe hypertension or diuretic use
  • Review all medications, especially:
    • Diuretics (thiazides, loops, potassium-sparing) 1
    • ACE inhibitors or ARBs
    • Beta-blockers

2. Screen for Renovascular Disease

Given the high renin state, evaluate for renal artery stenosis:

  • Renal artery duplex ultrasound (initial screening)
  • CT angiography or MR angiography if high suspicion 7
  • Look for clinical clues:
    • Abdominal bruit
    • Flash pulmonary edema
    • Asymmetric kidney sizes
    • Resistant hypertension despite multiple agents
    • Acute kidney injury with ACE inhibitor/ARB initiation

3. Assess for Malignant Hypertension

If blood pressure is severely elevated, examine for:

  • Papilledema on fundoscopy
  • Acute kidney injury
  • Microangiopathic hemolytic anemia
  • Neurologic symptoms 4, 5

Important Clinical Pitfall

Do NOT pursue primary aldosteronism workup (confirmatory testing, adrenal imaging, or adrenal vein sampling) in this patient. The ARR is not elevated, and further testing would be inappropriate and potentially harmful. 1

Some clinicians might see "elevated aldosterone" and reflexively think of primary aldosteronism, but the renin level is the critical distinguishing feature. In primary aldosteronism, renin is suppressed because aldosterone production is autonomous and independent of the renin-angiotensin system. 1, 2

Rare Exception to Consider

In extremely rare cases, patients with aldosterone-producing adenomas who develop severe renal insufficiency or malignant hypertension can paradoxically have elevated renin, creating a false-negative screening result 4, 8. However, this would require:

  • Documented severe hypertension (>180/110 mmHg)
  • Evidence of acute kidney injury or chronic kidney disease
  • Clinical features strongly suggesting primary aldosteronism despite the lab results

Even in this scenario, the initial focus should be on controlling the malignant hypertension and addressing renal dysfunction before reconsidering primary aldosteronism screening. 4

References

Guideline

neuroendocrine tumors.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Related Questions

In an 18-year-old hypertensive male with markedly elevated plasma renin activity and aldosterone at the upper limit of normal, what further work‑up should be pursued?
What does an elevated plasma renin activity and a low aldosterone-to-renin ratio indicate?
What labs are used to diagnose primary hyperaldosteronism (Primary Aldosteronism)?
In a patient with renal injury who presents with hypertension, what information does measuring plasma renin activity and aldosterone concentration provide?
Does a 27-year-old male on Lisinopril (Zestril) with elevated plasma renin activity and a low Aldosterone-to-Renin Ratio (ARR) require further evaluation for primary aldosteronism?
What does two units per carbohydrate choice mean for rapid-acting insulin dosing?
How should a 20-year-old patient with anemia, dizziness, a history of drug abuse, and current suboxone (buprenorphine/naloxone) therapy be evaluated and managed?
What are the FDA guidelines for the concomitant prescription of methadone and clonazepam?
Can tramadol be resumed after an intracranial hemorrhage?
In a 66-year-old man with hypertension and depression who presents with palpitations, blood pressure 128/66 mmHg, regular pulse 112 bpm, new-onset atrial fibrillation on ECG and normal left ventricular systolic function on point-of-care echocardiogram, what is the appropriate initial rate-control regimen (including drug choice and dosing) besides anticoagulation?
Is it safe for a healthy adult to take taurine together with St. John’s wort, and what are the appropriate dosages and precautions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.